$IMVT Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Immunovant, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Immunovant, Inc.. Get notifications about new insider transactions in Immunovant, Inc. for free.
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 23 2021 | IMVT | Immunovant, Inc. | MIGAUSKY GEORGE V | Director | Option Exercise | A | 17.00 | 23,300 | 396,100 | 23,300 | |
| Mar 23 2021 | IMVT | Immunovant, Inc. | MIGAUSKY GEORGE V | Director | Grant | A | 0.00 | 15,500 | 0 | 60,200 | 44.7 K to 60.2 K (+34.68 %) |
| Mar 23 2021 | IMVT | Immunovant, Inc. | Torti Frank | Director | Option Exercise | A | 17.00 | 28,900 | 491,300 | 28,900 | |
| Mar 23 2021 | IMVT | Immunovant, Inc. | Torti Frank | Director | Grant | A | 0.00 | 19,200 | 0 | 47,600 | 28.4 K to 47.6 K (+67.61 %) |
| Mar 23 2021 | IMVT | Immunovant, Inc. | Pande Atul | Director | Option Exercise | A | 17.00 | 23,300 | 396,100 | 23,300 | |
| Mar 23 2021 | IMVT | Immunovant, Inc. | Pande Atul | Director | Grant | A | 0.00 | 15,500 | 0 | 40,200 | 24.7 K to 40.2 K (+62.75 %) |
| Mar 23 2021 | IMVT | Immunovant, Inc. | Hughes Douglas J. | Director | Option Exercise | A | 17.00 | 23,300 | 396,100 | 23,300 | |
| Mar 23 2021 | IMVT | Immunovant, Inc. | Hughes Douglas J. | Director | Grant | A | 0.00 | 15,500 | 0 | 40,200 | 24.7 K to 40.2 K (+62.75 %) |
| Mar 23 2021 | IMVT | Immunovant, Inc. | Fromkin Andrew J. | Director | Option Exercise | A | 17.00 | 23,300 | 396,100 | 23,300 | |
| Mar 23 2021 | IMVT | Immunovant, Inc. | Fromkin Andrew J. | Director | Grant | A | 0.00 | 15,500 | 0 | 40,200 | 24.7 K to 40.2 K (+62.75 %) |
| Mar 23 2021 | IMVT | Immunovant, Inc. | Salzmann Peter | Chief Executive Off ... | Option Exercise | A | 17.00 | 464,700 | 7,899,900 | 464,700 | |
| Mar 23 2021 | IMVT | Immunovant, Inc. | Salzmann Peter | Chief Executive Off ... | Grant | A | 0.00 | 132,500 | 0 | 132,500 | 0 to 132.5 K |
| Mar 23 2021 | IMVT | Immunovant, Inc. | Yanchik Connealy Pamela | Chief Financial Off ... | Option Exercise | A | 17.00 | 162,000 | 2,754,000 | 162,000 | |
| Mar 23 2021 | IMVT | Immunovant, Inc. | Yanchik Connealy Pamela | Chief Financial Off ... | Grant | A | 0.00 | 46,200 | 0 | 46,200 | 0 to 46.2 K |
| Mar 23 2021 | IMVT | Immunovant, Inc. | Elliott Michael James | Chief Scientific Of ... | Option Exercise | A | 17.00 | 342,300 | 5,819,100 | 342,300 | |
| Mar 23 2021 | IMVT | Immunovant, Inc. | Elliott Michael James | Chief Scientific Of ... | Grant | A | 0.00 | 97,600 | 0 | 97,600 | 0 to 97.6 K |
| Mar 23 2021 | IMVT | Immunovant, Inc. | Jain Rita | Chief Medical Offic ... | Option Exercise | A | 17.00 | 342,300 | 5,819,100 | 342,300 | |
| Mar 23 2021 | IMVT | Immunovant, Inc. | Jain Rita | Chief Medical Offic ... | Grant | A | 0.00 | 109,365 | 0 | 129,365 | 20 K to 129.4 K (+546.83 %) |
| Mar 23 2021 | IMVT | Immunovant, Inc. | Butchko Julia G. | Chief Dev. & Tech. ... | Option Exercise | A | 17.00 | 191,100 | 3,248,700 | 191,100 | |
| Mar 23 2021 | IMVT | Immunovant, Inc. | Butchko Julia G. | Chief Dev. & Tech. ... | Grant | A | 0.00 | 54,500 | 0 | 59,500 | 5 K to 59.5 K (+1,090.00 %) |
| Jan 25 2021 | IMVT | Immunovant, Inc. | Jain Rita | Chief Medical Offic ... | Option Exercise | A | 42.19 | 220,000 | 9,281,800 | 220,000 | |
| Jan 25 2021 | IMVT | Immunovant, Inc. | Jain Rita | Chief Medical Offic ... | Grant | A | 0.00 | 20,000 | 0 | 20,000 | 0 to 20 K |
| Sep 18 2020 | IMVT | Immunovant, Inc. | Roivant Sciences Ltd. | 10% Owner | Buy | J | 0.00 | 8,773,969 | 0 | 56,367,388 | 47.6 M to 56.4 M (+18.44 %) |
| Sep 15 2020 | IMVT | Immunovant, Inc. | Butchko Julia G. | Chief Dev. & Tech. ... | Buy | P | 38.17 | 5,000 | 190,850 | 5,000 | 0 to 5 K |
| Sep 04 2020 | IMVT | Immunovant, Inc. | Roivant Sciences Ltd. | 10% Owner | Buy | P | 33.00 | 380,000 | 12,540,000 | 47,593,419 | 47.2 M to 47.6 M (+0.80 %) |
| Sep 04 2020 | IMVT | Immunovant, Inc. | Elliott Michael James | Chief Scientific Of ... | Option Exercise | A | 36.00 | 400,000 | 14,400,000 | 400,000 | |
| May 18 2020 | HSAC | Immunovant, Inc. | MIGAUSKY GEORGE V | Director | Option Exercise | A | 19.01 | 37,000 | 703,370 | 37,000 | |
| May 18 2020 | HSAC | Immunovant, Inc. | MIGAUSKY GEORGE V | Director | Grant | A | 0.00 | 24,700 | 0 | 24,700 | 0 to 24.7 K |
| May 18 2020 | HSAC | Immunovant, Inc. | Pande Atul | Director | Option Exercise | A | 19.01 | 37,000 | 703,370 | 37,000 | |
| May 18 2020 | HSAC | Immunovant, Inc. | Pande Atul | Director | Grant | A | 0.00 | 24,700 | 0 | 24,700 | 0 to 24.7 K |
| May 18 2020 | HSAC | Immunovant, Inc. | Hughes Douglas J. | Director | Option Exercise | A | 19.01 | 37,000 | 703,370 | 37,000 | |
| May 18 2020 | HSAC | Immunovant, Inc. | Hughes Douglas J. | Director | Grant | A | 0.00 | 24,700 | 0 | 24,700 | 0 to 24.7 K |
| May 18 2020 | HSAC | Immunovant, Inc. | Fromkin Andrew J. | Director | Option Exercise | A | 19.01 | 37,000 | 703,370 | 37,000 | |
| May 18 2020 | HSAC | Immunovant, Inc. | Fromkin Andrew J. | Director | Grant | A | 0.00 | 24,700 | 0 | 24,700 | 0 to 24.7 K |
| May 18 2020 | HSAC | Immunovant, Inc. | Torti Frank | Director | Option Exercise | A | 19.01 | 42,600 | 809,826 | 42,600 | |
| May 18 2020 | HSAC | Immunovant, Inc. | Torti Frank | Director | Grant | A | 0.00 | 28,400 | 0 | 28,400 | 0 to 28.4 K |
| May 18 2020 | HSAC | Immunovant, Inc. | Yanchik Connealy Pamela | Chief Financial Off ... | Option Exercise | A | 19.01 | 180,500 | 3,431,305 | 180,500 | |
| May 18 2020 | HSAC | Immunovant, Inc. | MIDDLEKAUFF W BRADFORD | General Counsel | Option Exercise | A | 19.01 | 142,600 | 2,710,826 | 142,600 | |
| May 18 2020 | HSAC | Immunovant, Inc. | Salzmann Peter | Chief Executive Off ... | Option Exercise | A | 19.01 | 430,700 | 8,187,607 | 430,700 | |
| May 18 2020 | HSAC | Immunovant, Inc. | Butchko Julia G. | Chief Dev. & Tech. ... | Option Exercise | A | 19.01 | 319,700 | 6,077,497 | 319,700 | |
| May 14 2020 | HSAC | Immunovant, Inc. | Roivant Sciences Ltd. | 10% Owner | Buy | J | 0.00 | 8,773,969 | 0 | 47,213,419 | 38.4 M to 47.2 M (+22.83 %) |
| Apr 17 2020 | HSAC | Immunovant, Inc. | Roivant Sciences Ltd. | 10% Owner | Buy | P | 14.50 | 1,034,483 | 15,000,004 | 38,439,450 | 37.4 M to 38.4 M (+2.77 %) |
| Dec 20 2019 | HSAC | Health Sciences Ac ... | Roivant Sciences Ltd. | 10% Owner | Option Exercise | J | 0.00 | 10,000 | 0 | 10,000 | |
| Dec 20 2019 | HSAC | Health Sciences Ac ... | Roivant Sciences Ltd. | 10% Owner | Buy | J | 10.00 | 36,919,967 | 369,199,670 | 37,404,967 | 485 K to 37.4 M (+7,612.36 %) |
| Dec 20 2019 | HSAC | Health Sciences Ac ... | Zeldin Robert K | Chief Medical Offic ... | Option Exercise | A | 7.86 | 380,325 | 2,989,355 | 380,325 | |
| Dec 20 2019 | HSAC | Health Sciences Ac ... | Yanchik Connealy Pamela | Chief Financial Off ... | Option Exercise | A | 8.43 | 433,588 | 3,655,147 | 433,588 | |
| Dec 20 2019 | HSAC | Health Sciences Ac ... | Torti Frank | Director | Option Exercise | A | 8.43 | 3,765 | 31,739 | 3,765 | |
| Dec 20 2019 | HSAC | Health Sciences Ac ... | Torti Frank | Director | Option Exercise | A | 8.43 | 11,488 | 96,844 | 11,488 | |
| Dec 20 2019 | HSAC | Health Sciences Ac ... | Torti Frank | Director | Option Exercise | A | 7.86 | 893 | 7,019 | 893 | |
| Dec 20 2019 | HSAC | Health Sciences Ac ... | Torti Frank | Director | Option Exercise | A | 7.86 | 137,617 | 1,081,670 | 137,617 | |
| Dec 20 2019 | HSAC | Health Sciences Ac ... | Salzmann Peter | Chief Executive Off ... | Option Exercise | A | 7.86 | 1,479,043 | 11,625,278 | 1,479,043 | |
| Dec 20 2019 | HSAC | Health Sciences Ac ... | POTTER MYRTLE S | Director | Option Exercise | A | 8.43 | 3,765 | 31,739 | 3,765 | |
| Dec 20 2019 | HSAC | Health Sciences Ac ... | POTTER MYRTLE S | Director | Option Exercise | A | 8.43 | 11,488 | 96,844 | 11,488 | |
| Dec 20 2019 | HSAC | Health Sciences Ac ... | POTTER MYRTLE S | Director | Option Exercise | A | 7.86 | 893 | 7,019 | 893 | |
| Dec 20 2019 | HSAC | Health Sciences Ac ... | POTTER MYRTLE S | Director | Option Exercise | A | 7.86 | 137,617 | 1,081,670 | 137,617 | |
| Dec 20 2019 | HSAC | Health Sciences Ac ... | Pande Atul | Director | Option Exercise | A | 8.43 | 77,181 | 650,636 | 77,181 | |
| Dec 20 2019 | HSAC | Health Sciences Ac ... | MIDDLEKAUFF W BRADFORD | General Counsel | Option Exercise | A | 7.86 | 489 | 3,844 | 489 | |
| Dec 20 2019 | HSAC | Health Sciences Ac ... | MIDDLEKAUFF W BRADFORD | General Counsel | Option Exercise | A | 7.86 | 211,277 | 1,660,637 | 211,277 | |
| Dec 20 2019 | HSAC | Health Sciences Ac ... | Hughes Douglas J. | Director | Option Exercise | A | 8.43 | 77,181 | 650,636 | 77,181 | |
| Dec 20 2019 | HSAC | Health Sciences Ac ... | Fromkin Andrew J. | Director | Option Exercise | A | 8.43 | 77,181 | 650,636 | 77,181 | |
| Dec 20 2019 | HSAC | Health Sciences Ac ... | Butchko Julia G. | Chief Dev. & Tech. ... | Option Exercise | A | 8.43 | 433,588 | 3,655,147 | 433,588 | |
| Dec 20 2019 | HSAC | Health Sciences Ac ... | Hughes Douglas J. | Director | Option Exercise | A | 8.43 | 77,181 | 650,636 | 77,181 | |
| Dec 20 2019 | HSAC | Health Sciences Ac ... | Fromkin Andrew J. | Director | Option Exercise | A | 8.43 | 77,181 | 650,636 | 77,181 | |
| Dec 20 2019 | HSAC | Health Sciences Ac ... | Butchko Julia G. | Chief Dev. & Tech. ... | Option Exercise | A | 8.43 | 433,588 | 3,655,147 | 433,588 | |
| Dec 20 2019 | HSAC | Health Sciences Ac ... | Health Sciences Holdings, LLC | 10% Owner | Option Exercise | J | 11.50 | 10,000,000 | 115,000,000 | 0 | |
| Dec 13 2019 | HSAC | Health Sciences Ac ... | WONG RODERICK | Chief Executive Off ... | Buy | P | 10.92 | 31,500 | 344,024 | 902,498 | 871 K to 902.5 K (+3.62 %) |
| Dec 10 2019 | HSAC | Health Sciences Ac ... | WONG RODERICK | Chief Executive Off ... | Buy | P | 10.38 | 25,971 | 269,517 | 870,998 | 845 K to 871 K (+3.07 %) |
| Dec 09 2019 | HSAC | Health Sciences Ac ... | WONG RODERICK | Chief Executive Off ... | Buy | P | 10.20 | 50,000 | 510,125 | 845,027 | 795 K to 845 K (+6.29 %) |
| Dec 09 2019 | HSAC | Health Sciences Ac ... | WONG RODERICK | Chief Executive Off ... | Buy | P | 10.25 | 400,000 | 4,100,000 | 795,027 | 395 K to 795 K (+101.26 %) |
| Dec 05 2019 | HSAC | Health Sciences Ac ... | WONG RODERICK | Chief Executive Off ... | Buy | P | 10.15 | 20,000 | 203,000 | 395,027 | 375 K to 395 K (+5.33 %) |
| Dec 04 2019 | HSAC | Health Sciences Ac ... | WONG RODERICK | Chief Executive Off ... | Buy | P | 10.15 | 20,000 | 203,000 | 375,027 | 355 K to 375 K (+5.63 %) |
| Dec 03 2019 | HSAC | Health Sciences Ac ... | WONG RODERICK | Chief Executive Off ... | Buy | P | 10.21 | 20,000 | 204,200 | 355,027 | 335 K to 355 K (+5.97 %) |
| Dec 03 2019 | HSAC | Health Sciences Ac ... | WONG RODERICK | Chief Executive Off ... | Buy | P | 10.40 | 20,000 | 208,000 | 335,027 | 315 K to 335 K (+6.35 %) |
| Dec 03 2019 | HSAC | Health Sciences Ac ... | WONG RODERICK | Chief Executive Off ... | Buy | P | 10.45 | 26,918 | 281,293 | 315,027 | 288.1 K to 315 K (+9.34 %) |
| Nov 29 2019 | HSAC | Health Sciences Ac ... | WONG RODERICK | Chief Executive Off ... | Buy | P | 10.48 | 4,000 | 41,904 | 288,109 | 284.1 K to 288.1 K (+1.41 %) |
| Nov 29 2019 | HSAC | Health Sciences Ac ... | WONG RODERICK | Chief Executive Off ... | Buy | P | 10.49 | 4,000 | 41,960 | 284,109 | 280.1 K to 284.1 K (+1.43 %) |
| Nov 29 2019 | HSAC | Health Sciences Ac ... | WONG RODERICK | Chief Executive Off ... | Buy | P | 10.50 | 4,000 | 42,000 | 280,109 | 276.1 K to 280.1 K (+1.45 %) |
| Nov 22 2019 | HSAC | Health Sciences Ac ... | WONG RODERICK | Chief Executive Off ... | Buy | P | 10.54 | 2,000 | 21,080 | 276,109 | 274.1 K to 276.1 K (+0.73 %) |
| Nov 22 2019 | HSAC | Health Sciences Ac ... | WONG RODERICK | Chief Executive Off ... | Buy | P | 10.42 | 15,194 | 158,299 | 274,109 | 258.9 K to 274.1 K (+5.87 %) |
| Nov 22 2019 | HSAC | Health Sciences Ac ... | WONG RODERICK | Chief Executive Off ... | Buy | P | 10.39 | 29,805 | 309,582 | 258,915 | 229.1 K to 258.9 K (+13.01 %) |
| Nov 19 2019 | HSAC | Health Sciences Ac ... | WONG RODERICK | Chief Executive Off ... | Buy | P | 10.25 | 29,805 | 305,501 | 229,110 | 199.3 K to 229.1 K (+14.95 %) |
| Nov 19 2019 | HSAC | Health Sciences Ac ... | WONG RODERICK | Chief Executive Off ... | Buy | P | 10.25 | 29,805 | 305,501 | 199,305 | 169.5 K to 199.3 K (+17.58 %) |
| Nov 19 2019 | HSAC | Health Sciences Ac ... | WONG RODERICK | Chief Executive Off ... | Buy | P | 10.29 | 13,000 | 133,800 | 169,500 | 156.5 K to 169.5 K (+8.31 %) |
| Nov 19 2019 | HSAC | Health Sciences Ac ... | WONG RODERICK | Chief Executive Off ... | Buy | P | 10.25 | 29,805 | 305,501 | 229,110 | 199.3 K to 229.1 K (+14.95 %) |
| Nov 19 2019 | HSAC | Health Sciences Ac ... | WONG RODERICK | Chief Executive Off ... | Buy | P | 10.25 | 29,805 | 305,501 | 199,305 | 169.5 K to 199.3 K (+17.58 %) |
| Nov 19 2019 | HSAC | Health Sciences Ac ... | WONG RODERICK | Chief Executive Off ... | Buy | P | 10.29 | 13,000 | 133,800 | 169,500 | 156.5 K to 169.5 K (+8.31 %) |
| Nov 14 2019 | HSAC | Health Sciences Ac ... | WONG RODERICK | Chief Executive Off ... | Buy | P | 10.17 | 13,000 | 132,210 | 156,500 | 143.5 K to 156.5 K (+9.06 %) |
| Nov 14 2019 | HSAC | Health Sciences Ac ... | WONG RODERICK | Chief Executive Off ... | Buy | P | 10.17 | 13,000 | 132,210 | 143,500 | 130.5 K to 143.5 K (+9.96 %) |
| Nov 14 2019 | HSAC | Health Sciences Ac ... | WONG RODERICK | Chief Executive Off ... | Buy | P | 10.17 | 100,000 | 1,017,000 | 130,500 | 30.5 K to 130.5 K (+327.87 %) |
| Nov 12 2019 | HSAC | Health Sciences Ac ... | WONG RODERICK | Chief Executive Off ... | Buy | P | 10.18 | 13,000 | 132,340 | 30,500 | 17.5 K to 30.5 K (+74.29 %) |
| Nov 12 2019 | HSAC | Health Sciences Ac ... | WONG RODERICK | Chief Executive Off ... | Buy | P | 10.18 | 17,500 | 178,150 | 17,500 | 0 to 17.5 K |
| May 15 2019 | HSAC | Health Sciences Ac ... | Health Sciences Holdings, LLC | 10% Owner | Option Exercise | P | 11.50 | 10,000,000 | 115,000,000 | 10,000,000 |
Page: 1